MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
Kumar Rishabh,Soham Khadilkar,Aviral Kumar,Ishu Kalra,Alan Prem Kumar,Ajaikumar B. Kunnumakkara +5 more
Reads0
Chats0
TLDR
In this paper, the role of microRNAs in regulating various hallmarks of oral tumorigenesis is discussed, including sustaining proliferative signaling, evading growth suppressors, resisting cell death activating invasion and metastasis, and inducing angiogenesis.Abstract:
Oral cancers constitute the majority of head and neck tumors, with a relatively high incidence and poor survival rate in developing countries. While the five-year survival rates of the oral cancer patients have increased to 65%, the overall survival for advanced stages has been at 27% for the past ten years, emphasizing the necessity for further understanding the etiology of the disease, diagnosis, and formulating possible novel treatment regimens. MicroRNAs (miRNAs), a family of small non-coding RNA, have emerged as master modulators of gene expression in various cellular and biological process. Aberrant expression of these dynamic molecules has been associated with many human diseases, including oral cancers. The deregulated miRNAs have been shown to control various oncogenic processes, including sustaining proliferative signaling, evading growth suppressors, resisting cell death activating invasion and metastasis, and inducing angiogenesis. Hence, the aberrant expression of miRNAs associated with oral cancers, makes them potential candidates for the investigation of functional markers, which will aid in the differential diagnosis, prognosis, and development of novel therapeutic regimens. This review presents a holistic insight into our understanding of the role of miRNAs in regulating various hallmarks of oral tumorigenesis.read more
Citations
More filters
Journal ArticleDOI
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh,Maliheh Entezari,Sepideh Mirzaei,Amirhossein Zabolian,Hossein Saleki,Mohamad Javad Naghdi,Sina J. Sabet,M. Khoshbakht,M. Hashemi,Kiavash Hushmandi,Gautam Sethi,Ali Zarrabi,Alan Prem Kumar,Shing Cheng Tan,N. Papadakis,Athanasios Alexiou,Md. Asiful Islam,Ebrahim Mostafavi,Milad Ashrafizadeh +18 more
TL;DR: The role of exosomes in cancer progression and therapy is discussed in this article , where the authors provide a comprehensive understanding of the role of the exosome in cancer therapy, focusing on their therapeutic value in cancer progress and remodeling of the tumor microenvironment.
Journal ArticleDOI
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh,Mahshid Deldar Abad Paskeh,Sepideh Mirzaei,Mohammad Hossein Gholami,Ali Zarrabi,Farid Hashemi,Kiavash Hushmandi,M. Hashemi,Noushin Nabavi,Francesco Crea,Jun Ren,Daniel J. Klionsky,Alan Prem Kumar,Yuzhuo Wang +13 more
TL;DR: In this paper , the authors provided a mechanistic discussion of autophagy in prostate cancer and found that autophagous cells can promote/inhibit proliferation and survival of prostate cancer cells.
Journal ArticleDOI
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh,Mahshid Deldar Abad Paskeh,Sepideh Mirzaei,Mohammad Hossein Gholami,Ali Zarrabi,Farid Hashemi,Kiavash Hushmandi,M. Hashemi,Noushin Nabavi,Francesco Crea,Jun Ren,Daniel J. Klionsky,Alan Prem Kumar,Yuzhuo Wang +13 more
TL;DR: In this paper , the authors provided a mechanistic discussion of autophagy in prostate cancer and found that autophagous cells can promote/inhibit proliferation and survival of prostate cancer cells.
Journal ArticleDOI
miRNAs in Cancer (Review of Literature)
TL;DR: The current knowledge about the possibility of using miRNA as a diagnostic marker and a potential target in modern anticancer therapies is discussed.
Journal ArticleDOI
Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
Krishan Kumar Thakur,Aviral Kumar,Kishore Banik,Elika Verma,Elina Khatoon,Choudhary Harsha,Gautam Sethi,Subash C. Gupta,Ajaikumar B. Kunnumakkara +8 more
TL;DR: In this paper, a review highlights the association of several lncRNAs in TNBC progression and treatment, along with their possible functions and mechanisms, and extensive research is being carried out to reveal it.
References
More filters
Journal ArticleDOI
Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Tao Liu,Gang Chen,Dawei Sun,Minghui Lei,Yongqiang Li,Changming Zhou,Xiaodong Li,Wei Xue,Hong Wang,Chunjun Liu,Jiang Xu +10 more
TL;DR: Exosomes derived from cisplatin-resistant OSCC cells were found to enhance the chemoresistance of OSCC cell and decrease the DNA damage signaling in response to cisPlatin.
Journal ArticleDOI
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Milad Ashrafizadeh,Kiavash Hushmandi,Mehrdad Hashemi,Mohammad Esmaeil Akbari,Peter Kubatka,Mehdi Raei,Lenka Koklesova,Shahinozzaman,Reza Mohammadinejad,Masoud Najafi,Gautam Sethi,Alan Prem Kumar,Ali Zarrabi +12 more
TL;DR: This review focuses on microRNAs (miRNAs) and their regulatory effect on epithelial-to-mesenchymal transition (EMT) mechanisms that can regulate metastasis ofadder cancer cells.
Journal ArticleDOI
Recent progress in microRNA-based delivery systems for the treatment of human disease
TL;DR: Some representative advances related to the application of viral- and nonviral-mediated miRNA delivery systems are discussed and a new perspective on the future of miRNA-based therapeutic strategies is provided.
Journal ArticleDOI
MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
TL;DR: Investigation of the effects of miR‐133a‐3p on human oral squamous cell carcinoma (OSCC) cells by regulating gene COL1A1 found it could inhibit the proliferation and migration of OSCC cells through directly targeting COL 1A1 and reducing its expression.
Journal ArticleDOI
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
TL;DR: The data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth, and may be a rational for diagnostic and therapeutic applications in OSCC.